Optimising intratumoral treatment of head and neck squamous cell carcinoma models with the diterpene ester Tigilanol tiglate
This study confirmed that TT in 40% PG given intratumorally as a single bolus dose was the most efficacio us treatment for a tongue SCC mouse model.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Cancer & Oncology | Carcinoma | Clinical Trials | Drugs & Pharmacology | HNSCC | Investigational New Drugs | Skin Cancer | Squamous Cell Carcinoma | Study